- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04158388
Effects of Nutritional Strategies or Manual Therapies in Women With Fibromyalgia
May 8, 2020 updated by: Prof. Dr. Alejandro Martínez-Rodríguez, University of Alicante
Effects of Nutritional Strategies or Manual Therapies on Physical and Psychological Parameters in Women With Fybromyalgia.
The study had two objectives.
The first main aim was to analyze the effects of tryptophan and magnesium-enriched Mediterranean diet on psychological variables (trait anxiety, self-image, mood state, eating disorders) and sleep effects in women with fibromyalgia.
Our hypothesis, based on previous positive effects of tryptophan and magnesium supplementation by separate in this population, may improve psychological health and regulate sleep disruptions.
The second aim was to assess the effectiveness of a manual therapy technique performed with moderate digital pressure in fibromyalgia patients on the variables of fatigue, pain, sleep, anxiety and mood.
It was done to provide an alternative treatment to pharmacological therapies for fibromyalgia patients and to provide new evidence on the effects of manual therapy in fibromyalgia patients.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
San Vicente Del Raspeig
-
Alicante, San Vicente Del Raspeig, Spain, 03690
- University of Alicante
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
38 years to 58 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women aged 40-60 with fibromialgia (officially diagnosed).
Exclusion Criteria:
- Women used analgesics, vitamins containing supplements, and or other drugs for the treatment of fibromyalgia symptoms, or participation in other clinical trials.
- Women that be performing simultaneously to this study some other physical therapy or physical exercise treatment. Not having sufficient cognitive level to collaborate in the study or not having the possibility of attending the established sessions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: EXPERIMENTAL DIET GROUP
|
That gruop eaten at both breakfast and dinner from walnuts (3-5 units), as food with high values of tryptophan and magnesium
|
Other: CONTROL GROUP
|
That group eaten isocaloric diet plan based on Mediterranean diet.
|
Experimental: EXPERIMENTAL MASSAGE GROUP
That group received moderate pressure digital manual therapy.
|
That group received moderate pressure digital manual therapy.
|
Experimental: EXPERIMENTAL PLACEBO GROUP
That group was treated with a US (in off mode) without conductive gel.
Placebo group.
|
That group was treated with a US (in off mode) without conductive gel.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sleep Quality
Time Frame: 4 - 16 weeks
|
Sleep Quality assessment: Athenas Insomnia Scale.
|
4 - 16 weeks
|
Anxiety trait
Time Frame: 4 - 16 weeks
|
Anxiety trait assessment: Stay Trait Anxiety Inventory.
|
4 - 16 weeks
|
Mood state
Time Frame: 4 - 16 weeks
|
Mood state assessment: Profile of Mood State inventory.
|
4 - 16 weeks
|
Fatigue severity
Time Frame: 4 - 16 weeks
|
Fatigue severity assessment: Fatigue Severity Scale
|
4 - 16 weeks
|
Pain perception
Time Frame: 4 - 16 weeks
|
Pain perception assessment: Visual Analogical Scale
|
4 - 16 weeks
|
Sleep quality
Time Frame: 4 - 16 weeks
|
Sleep quality assessment: Pittsburgh Sleep Quality Index
|
4 - 16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body composition
Time Frame: 4 - 16 weeks
|
Body composition assessment trough bioimpedance.
|
4 - 16 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2019
Primary Completion (Actual)
October 9, 2019
Study Completion (Actual)
October 10, 2019
Study Registration Dates
First Submitted
October 14, 2019
First Submitted That Met QC Criteria
November 7, 2019
First Posted (Actual)
November 8, 2019
Study Record Updates
Last Update Posted (Actual)
May 12, 2020
Last Update Submitted That Met QC Criteria
May 8, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UA-2019-04-10
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
University of AberdeenCompletedFibromyalgia | Fibromyalgia, Primary | Fibromyalgia, SecondaryUnited Kingdom
-
Eli Lilly and CompanyCompletedFibromyalgia, Primary | Fibromyalgia, SecondaryMexico
-
Rasmia ElgoharyNot yet recruiting
-
Tel-Aviv Sourasky Medical CenterCompletedFibromyalgia (FM)Israel
-
Yousra Hisham Abdel FattahCompletedFibromyalgia, PrimaryEgypt
-
Forest LaboratoriesCypress Bioscience, Inc.TerminatedPrimary FibromyalgiaUnited States
-
Universidade Federal do Rio Grande do NorteCompleted
-
Tonix Pharmaceuticals, Inc.CompletedPrimary FibromyalgiaUnited States
-
Tonix Pharmaceuticals, Inc.CompletedPrimary FibromyalgiaUnited States
-
University of ManitobaCompleted
Clinical Trials on Mediterranean-diet enriched with a higher dose of tryptophan and magnesium
-
Unity Health TorontoUniversity of Manitoba; University of Toronto; Laval University; Canola Council...CompletedCardiovascular Diseases | Obesity | Overweight | Type 2 DiabetesCanada
-
University of TorontoMount Sinai Hospital, CanadaCompletedObesity | OverweightCanada
-
ANTONIOS KOUTELIDAKISDemocritus University of Thrace; University of IoanninaEnrolling by invitation
-
Washington University School of MedicineCompletedMicrobiota | Gastrointestinal MicrobiomeUnited States
-
University of SalamancaNot yet recruitingAlzheimer Disease | Fall | Bone Density | Physical ExerciseSpain
-
Voronezh N.N. Burdenko State Medical AcademyCompletedUlcer HemorrhageRussian Federation
-
National Cancer Institute, NaplesUnity Health Toronto; University of CataniaActive, not recruiting
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsUnited States
-
Hartford HospitalRecruitingAlcohol Drinking | Marijuana UsageUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompletedDiarrhea | Clostridium Difficile InfectionUnited States